Evaluating treatment efficacy for obsessive-compulsive disorder: Caveat practitioner

Cognitive and Behavioral Practice

Volumn 6, Issue 4, 1999, Pages 422-426

  Kozak, Michael J ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0005867303     PISSN: 10777229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1077-7229(99)80061-3     Document Type: Article

References (20)

1. Abramowitz, J. (1997). Effectiveness of psychological and pharmacological treatment for obsessive compulsive disorder: A quantitative review. Journal of Consulting and Clinical Psychology, 65, 44-52.
2. Abramowitz, J. S., Franklin, M. E., & Foa, E. B. (1999). Empirical status of cognitive behavioral therapy for obsessive compulsive disorder: A meta-analytic review. Unpublished manuscript.
3. Clark, D. A. (1999). Cognitive behavioral treatment of obsessive compulsive disorders: A commentary. Cognitive and Behavioral Practice, 6, 408-415.
4. DeVeaugh-Geiss, J., Katz, R., Landau, P., Akiskal, H., Ananth, J., Ballenger, J., Betts, W. C., Diamond, B., Feiger, A., Foa, E., Fogelson, D., Goodman, W., Greist, J., Himmelhoch, J., Hoehn-Saric, R., Jenike, M., Kim, S. W. Liebowitz, M., Mavissakalian, M., Ninan, P., Noyes, R., Rasmussen, S. Ringold, A., & Shear, K. (1991). Clomipramine in the treatment of patients with obsessive-compulsive disorder: The clomipramine collaborative study group. Archives of General Psychiatry, 48, 730-738.
5. DeVeaugh-Geiss, J., Landau, P., & Katz, R. (1989). Treatment of OCD with clomipramine. Psychiatric Annals, 19, 97-101.
6. Foa, E. B., & Kozak, M. J., (1986). Emotional processing of fear: Exposure to corrective information. Psychological Bulletin, 99, 20-35.
7. Foa, E. B., & Kozak, M. J. (1996). Psychological treatment for obsessive compulsive disorder. In M. R. Mavissakalian & R. F. Prien (Eds.), Long-term treatments of anxiety disorders (pp. 285-309). Washington, DC: American Psychiatric Press.
8. Franklin, M., & Foa, E. B. (1998). Cognitive-behavioral treatments for obsessive compulsive disorder. In P. Nathan & J. Gorman (Eds.), A guide to treatments that work (pp. 339-357). New York: Oxford University Press.
9. Goodman, W. K., Steiner, M., Bushnell, W., Gergel, I. P., & Wheadon, D. E. (1996). Efficacy of fixed doses of paroxeline in the treatment of obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial. Unpublished manuscript.
10. Greist, J. H., Jefferson, J. W., Kobak, K. A., Chouinard, G., DuBoff, E., Halaris, A., Kim, S. W., Koran, L., Liebowitz, M. R., & Lydiard, B. (1995). A one-year double-blind placebo-controlled fixed dose study of sertraline in the treatment of OCD. International Journal of Clinical Psychopharmacology, 10(2), 57-65.
11. Greist, J. H., Jefferson, J. W., Kobak, K. A., Katzelnick, D. J., & Serlin, R. C. (1995). Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: A meta analysis. Archives of General Psychiatry, 52, 53-60.
12. Hollander, E. (1993). (Ed.). Obsessive-compulsive related disorders. Washington, DC: American Psychiatric Press.
13. Kozak, M. J., Liebowitz, M., & Foa, E. B. (in press). Cognitive-behavior therapy and pharmacotherapy for OCD: The NIMH-sponsored collaborative study. In W. K. Goodman, M. Rudorfer, & J. Maser (Eds.), Treatment challenges in obsessive compulsive disorder.
14. March, J. S., Biederman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E. H., Cutler, N. R., Domingues, R., Ferguson, J., Muller, B., Riesenberg, R., Rosenthal, M., Sallee, R., & Wagner, K. (1998). Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial. Journal of the American Medical Association, 280, 20, 1752-1756.
15. March, J. S., Frances, A., Carpenter, D., & Kahn, M. D. (1997). The expert consensus panel guideline series: Treatment of obsessive compulsive disorder. Journal of Clinical Psychiatry, 58(Suppl. 4).
16. Neziroglu, F., Stevens, K. P., Yaryura-Tobias, J. A., & Hoffman, J. H. (1999). Assessment, treatment parameters, and prognostic indicators for patients with obsessive-compulsive spectrum disorders. Cognitive and Behavioral Practice, 6, 345-350.
17. Rasmussen, S. A., Goodman, W. K., Greist, J. J., Jenike, M. A., Kozak, M. J., Liebowitz, M. R., Robinson, D. G., & White, K. L. (1993). Fluvoxamine in the treatment of obsessive compulsive disorder: A multicenter double-blind placebo-controlled study in outpatients.
18. Stanley, M. A., & Turner, S. M. (1995). Current status of pharmacological and behavioral treatment of obsessive-compulsive disorder. Behavior Therapy, 26, 163-186.
19. Tollefson, G. D., Rampey, A. H., Potvin, J. H., Jenike, M. A., Rush, A. J., Domingues, R. A., Koran, L. M., Shear, M. K., Goodman, W. K., & Genduso, L. A. (1994). A multi-center investigation of fixed-dose fluoxetine in the treatment of obsessive compulsive disorder. Archives of General Psychiatry, 51, 559-567.
20. Whittal, M. L., & McLean P. D. (1999). CBT for OCD: The rationale, protocol, and challenges. Cognitive and Behavioral Practice, 6, 383-396.